摘要
目的探讨布地奈德福莫特罗粉联合孟鲁司特对儿童支气管哮喘并变应性鼻炎的疗效。方法随机选取该院儿科病房近3年共100例哮喘并变应性鼻炎的患儿作为研究对象,随机分为2组,联合组50例和对照组50例。联合组使用布地奈德福莫特罗粉联合孟鲁司特;对照组仅使用布地奈德福莫特罗粉。评价两组不同时期鼻炎症状评分以及哮喘症状评分,以及治疗前及治疗后肺功能差异。结果联合组和对照组治疗前鼻炎症状评分、哮喘症状评分及FEV1差异无统计学意义(P>0.05)。联合组和对照组治疗后鼻炎症状评分、哮喘症状评分及FEV1差异有统计学意义(P<0.05)。结论本次研究认为孟鲁司特联合布地奈德福莫特罗粉治疗儿童支气管哮喘并变应性鼻炎疗效肯定,能显著改善患者肺功能情况。
Objective To explore the effect of Budesonide/Fomoterol and montelukast in Children bronchial asthma and allergic rhinitis. Methods To collect the pediatric ward in our hospital in recent 3 years a total of 100 patients with asthma and allergic rhinitis patients as the research object, randomly divided into 2 groups, combined group 50 cases and control group with 50 cases. The combined group using budesonide and formoterol fumarate powder combined with montelukast; the control group onlyusing Bbu Di Ned Fumo Tero powder. Evaluation of two groups of differentperiod rhinitis symptom score and asthma symptoms score, and lung functionbefore and after treatment the difference. Results In the combined group and control group before treatment rhinitis symptom score, asthma symptom score and FEV1 were no significant difference （P〉0.05）. The combined group and control group after treatment, symptoms of rhinitis, asthma symptoms score and FEV1 score were statistically significant （P〈0.05）. Conclusion This research certainly thinks of montelukast and budesonide and formoterol fumarate powder for the treatment of children with bronchial asthma and allergic rhinitis curative effect, can significantly improve lung function in patients with.
出处
《中外医疗》
2015年第13期119-120,共2页
China & Foreign Medical Treatment
